WallStSmart
CMND

Clearmind Medicine Inc. Common Shares

NASDAQ: CMND · HEALTHCARE · BIOTECHNOLOGY

$0.97
-1.52% today

Updated 2026-09-11

Market cap
$1.44M
P/E ratio
P/S ratio
EPS (TTM)
$-57.79
Dividend yield
52W range
$1 – $524
Volume
0.8M

WallStSmart proprietary scores

26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
6.0
Quality
B
3.0
Profitability
D
5.0
Valuation
C+
1/9
Piotroski F-Score
Weak
-8.1
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target
12-Month target
Intrinsic (DCF)
Margin of safety

Price chart

Stock snapshot

Strengths
+ Debt/equity 0.01x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -8.11 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-1.79M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$0.00$0.00
Net income$-9.93M$-8.61M$-5.25M$-3.86M$-2.05M
EPS$-57.79
Free cash flow$-5.06M$-6.30M$-6.76M$-4.73M$-1.79M
Profit margin

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CMND$1.44M264.33.05.06.0Avoid
LLY$994.92B769.310.05.06.0Strong Buy
JNJ$640.02B594.78.52.76.0-88.93%Buy
ABBV$454.36B736.78.54.05.0-69.36%Strong Buy
MRK$355.10B364.04.52.05.0-73.74%Hold
UNH$340.27B627.35.54.76.0-16.10%Buy

Smart narrative

Clearmind Medicine Inc. Common Shares trades at $0.97. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -8.11, it sits in the distress.

Frequently asked questions

What is Clearmind Medicine Inc. Common Shares's stock price?

Clearmind Medicine Inc. Common Shares (CMND) trades at $0.97.

Is Clearmind Medicine Inc. Common Shares overvalued?

Clearmind Medicine Inc. Common Shares carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Clearmind Medicine Inc. Common Shares's Altman Z-Score is -8.11, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-93.63%
Beta-1.14
50D MA$1.73
200D MA$12.01
Shares out0.00B
Float0.00B
Short ratio
Avg volume0.8M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years